Author

Yan Li

Institution: Guangdong Pharmaceutical University

Observed institutions: Guangdong Pharmaceutical University, Key Laboratory of Guangdong Province, First Affiliated Hospital of Guangdong Pharmaceutical University

ORCID: 0000-0003-3153-6396

Observed ORCID: 0000-0003-3153-6396

OpenAlex ID: A5005597753

M 6 A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 + T cells and phagocytosis of macrophages

2024 · Qing Xi, Guangze Yang, et al. · Advanced Science · 40

Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma

2024 · Xin Li, Xue He, et al. · The American Journal of Chinese Medicine · 22

Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy Response in Colorectal Cancer

2022 · Huijiao Lu, Mengyi Zhu, et al. · Cancers · 19

A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint

2023 · Huijiao Lu, Jiahua Liang, et al. · International Journal of Molecular Sciences · 18

CircRNAs: A Promising Star for Treatment and Prognosis in Oral Squamous Cell Carcinoma

2023 · Mengyi Zhu, Daoyang Chen, et al. · International Journal of Molecular Sciences · 15

Fasting as an Adjuvant Therapy for Cancer: Mechanism of Action and Clinical Practice

2024 · Yichun Xie, Huabin Ye, et al. · Biomolecules · 11

Sp3 ameliorated experimental autoimmune encephalomyelitis by triggering Socs3 in Th17 cells

2025 · Yan Li, Mengyi Zhu, et al. · Journal of Advanced Research · 5

Immune checkpoint inhibitors plus chemotherapy in the first-line treatment of young unresectable gastric cancer patients: a multicentre real-world study

2025 · Yingnan Wang, Yan Li, et al. · Frontiers in Oncology · 3

Novel Oncogenic Value of C10orf90 in Colon Cancer Identified as a Clinical Diagnostic and Prognostic Marker

2024 · Chuangdong Ruan, Yuqin Zhang, et al. · International Journal of Molecular Sciences · 2

The fragility and dual biological functions of PARK2 in neuroinflammation and tumorigenesis

2026 · Chuangdong Ruan, Penghui Yang, et al. · Genes & Diseases

Role of fragile sites FATS and FMR1 in tumor progression and their potential clinical significance

2025 · Chuangdong Ruan, Yichun Xie, et al. · International Journal of Cancer

Works count: 11

Citation count: 135

H-index: 6

I10-index: 6